Concepedia

Axel‐R. Hanauske

AH

35

Publications

2K

Citations

23

H-Index

1981

Active since

Affiliations

Technical University of Munich(Current)

Klinikum rechts der Isar

Asklepios Klinik St. Georg

The University of Texas Health Science Center at San Antonio

European Organisation for Research and Treatment of Cancer

Axel‐R. Hanauske is an author at Technical University of Munich specializing in medicine, pharmacology, and cancer research.

Top concepts

Publications per year

1981–2010

35

Publications

35

Docetaxel (Taxotere®): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck

G. Catimel, Jaap Verweij, Vera Mattijssen et al. · Annals of Oncology · 1994 · 258 citations

, , +7

Activity of Topotecan, a New Topoisomerase I Inhibitor, Against Human Tumor Colony-Forming Units In Vitro

H.A. Burris, Axel‐R. Hanauske, Randall K. Johnson et al. · JNCI Journal of the National Cancer Institute · 1992 · 170 citations

Clinical and Pharmacokinetic Phase I Study of Multitargeted Antifolate (LY231514) in Combination With Cisplatin

R. Thödtmann, H. Depenbrock, Herlinde Dumez et al. · Journal of Clinical Oncology · 1999 · 151 citations

Inhibition of the G1-S transition of the cell cycle by inhibitors of deoxyhypusine hydroxylation

Hartmut M. Hanauske‐Abel, M.-H. Park, Axel‐R. Hanauske et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 1994 · 149 citations

, , +9

Clinical phase I and pharmacokinetic trial of the new titanium complex budotitane

T. Schilling, K. B. Keppler, Manfred Heim et al. · Investigational New Drugs · 1995 · 146 citations

, , +2

Rows per page

1–5 of 35